Cryptococcal Meningitis in Patients with or without Human Immunodeficiency Virus: Experience in a Tertiary Hospital
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose: Cryptococcal meningitis is a relatively common opportunistic infection in human immunodeficiency virus (HIV) patients and it can frequently occur in immunocompetent hosts without any apparent underlying disease. Nevertheless, little is known about cyptococcal meningitis in the Korean population. The purpose of this study was to evaluate the clinical features and initial laboratory findings of cryptococcal meningitis in patients with and without HIV at a tertiary care teaching hospital. Materials and Methods: We performed a retrospective study at a tertiary care teaching hospital from January 2001 to December 2009. Eleven HIV positive patients and nine HIV negative patients were included. Results: The most common symptoms were headache and fever in cryptococcal meningitis, and diabetic mellitus,end stage renal disease and liver cirrhosis were the main associated conditions in patients without HIV. Patients with HIV showed lower peripheral CD4+ cell counts (median: 9, range: 1-107) and a higher burden of cryptococcus than patients without HIV. There were no statistically significant differences in serum CRP level and other cerebrospinal fluid parameters between patients with HIV and without HIV. The in-hospital mortality was 10%, and recurrence of cyptococcal meningitis was observed in 3 patients with HIV and this occurred within 5 months of the first episode. Conclusion: Cryptococcal meningitis is fatal without treatment, therefore, rapid recognition of symptoms such as fever and headache and diagnosis is required to decrease the mortality. Recurrence of meningitis after treatment should carefully be followed up, especially in advanced HIV patients.
Abstract
Purpose: Cryptococcal meningitis is a relatively common opportunistic infection in human immunodeficiency virus (HIV) patients and it can frequently occur in immunocompetent hosts without any apparent underlying disease. Nevertheless, little is known about cyptococcal meningitis in the Korean population. The purpose of this study was to evaluate the clinical features and initial laboratory findings of cryptococcal meningitis in patients with and without HIV at a tertiary care teaching hospital. Materials and Methods: We performed a retrospective study at a tertiary care teaching hospital from January 2001 to December 2009. Eleven HIV positive patients and nine HIV negative patients were included. Results: The most common symptoms were headache and fever in cryptococcal meningitis, and diabetic mellitus,end stage renal disease and liver cirrhosis were the main associated conditions in patients without HIV. Patients with HIV showed lower peripheral CD4+ cell counts (median: 9, range: 1-107) and a higher burden of cryptococcus than patients without HIV. There were no statistically significant differences in serum CRP level and other cerebrospinal fluid parameters between patients with HIV and without HIV. The in-hospital mortality was 10%, and recurrence of cyptococcal meningitis was observed in 3 patients with HIV and this occurred within 5 months of the first episode. Conclusion: Cryptococcal meningitis is fatal without treatment, therefore, rapid recognition of symptoms such as fever and headache and diagnosis is required to decrease the mortality. Recurrence of meningitis after treatment should carefully be followed up, especially in advanced HIV patients.
참고문헌 (19)
- Levitz SM, "The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis", Rev Infect Dis, 13, pp.1163~1169 (1991)
- Perfect JR, "Cryptococcosis", Infect Dis Clin North Am, 16, pp.837~374 (2002)
- Pappas PG, "Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy", Clin In fect Dis, 33, pp.690~699 (2001)
- Igel HJ, "Humoral defense mechanisms in cryptococcosis: substances in normal human serum, saliva, and cerebrospinal fluid affecting the growth of Cryptococcus neoformans", J Infect Dis, 116, pp.75~83 (1966)
- Diamond RD, "The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection", J Immunol, 112, pp.2260~2270 (1974)
- Jarvis JN, "HIV associated cryptococcal meningitis", AIDS, 21, pp.2119~2129 (2007)
- Graybill JR, "Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups", Clin Infect Dis, 30, pp.47~54 (2000)
- Saag MS, "Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group", N Engl J Med, 326, pp.83~89 (1992)
- Saag MS, "Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America", Clin Infect Dis, 30, pp.710~718 (2000)
- Bicanic T, "Cryptococcal meningitis", Br Med Bull, 72, pp.99~118 (2005)
- Cox GM, "Cryptococcus neoformans var neoformans and gattii and Trichosporon species. In Topley and Wilson’s Microbiology and Microbial Infections, 9th ed" (1997), Arnold Press
- Kisenge PR, "Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania", BMC Infect Dis, 7, pp.39~ (2007)
- Tanner DC, "Comparison of commercial kits for detection of cryptococcal antigen", J Clin Microbiol, 32, pp.1680~1684 (1994)
- Crowe SM, "Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV infected persons", J Acquir Immune Defic Syndr, 4, pp.770~776 (1991)
- van der Horst CM, "Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Disease Mycoses Study Group and AIDS Clinical Trials Group", N Engl J Med, 337, pp.15~21 (1997)
- Lortholary O, "Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy", AIDS, 20, pp.2183~2191 (2006)
- Brouwer AE, "Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomized trial", Lancet, 363, pp.1764~1767 (2004)
- Robinson PA, "Early mycological treatment failure in AIDS-associated cryptococcal meningitis", Clin Infect Dis, 28, pp.82~92 (1999)
- Choi KG, "A clinical study of cryptococcal infection", J Korean Neurol Assoc, 2, pp.14~20 (1984)